RPGLF (Regent Pacific Group) Issuance of Debt: $4.86 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RPGLF Regent Pacific Group Ltd RPGLF
12 GF Score
Price $0.01
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group Issuance of Debt?

Regent Pacific Group RPGLF 12 Issuance of Debt is $4.86 Mil as of Dec. 2025. GuruFocus rates RPGLF with a GF Score™ of 12/100. The stock has 7 warning signs investors should review.

Regent Pacific Group's Issuance of Debt for the six months ended in Dec. 2025 was $2.38 Mil.

Regent Pacific Group's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was $4.86 Mil.

Regent Pacific Group Issuance of Debt Related Terms

Regent Pacific Group Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Regent Pacific Group's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regent Pacific Group Issuance of Debt Chart

Regent Pacific Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 2.52 0.00 2.83 4.86

Regent Pacific Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.72 1.85 2.48 2.38
RPGLF
12GF Score
Regent Pacific Group Ltd RPGLF
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regent Pacific Group Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $4.86 Mil mean?
Regent Pacific Group (RPGLF) has a Issuance of Debt of $4.86 Mil as of Dec. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Regent Pacific Group and its competitors.
Is Regent Pacific Group's Issuance of Debt too high?
Regent Pacific Group's current Issuance of Debt is $4.86 Mil. Overall, Regent Pacific Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Regent Pacific Group's Issuance of Debt compare to ZTS and UTHR?
Regent Pacific Group's Issuance of Debt of $4.86 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Regent Pacific Group and its competitors. Regent Pacific Group's current Issuance of Debt is $4.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regent Pacific Group stock overvalued right now?
Regent Pacific Group (RPGLF) has a current Issuance of Debt of $4.86 Mil. The current Issuance of Debt is $4.86 Mil. Regent Pacific Group's overall GF Score™ is 12/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Regent Pacific Group (RPGLF), the current Issuance of Debt is $4.86 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regent Pacific Group Business Description

Other Exchanges 00575:Hong KongRPG:Germany
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
12GF Score

Get the complete analysis for RPGLF

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price